Pregnancy in women with congenital physical disabilities: Risk factors, birth outcomes, and mediation

先天性身体残疾妇女的怀孕:危险因素、出生结局和调解

基本信息

  • 批准号:
    9883035
  • 负责人:
  • 金额:
    $ 8.25万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-01 至 2022-03-31
  • 项目状态:
    已结题

项目摘要

The average lifespan of individuals born with most congenital malformations has vastly improved in the past decades, allowing the majority to survive through the reproductive years. Because the presence of a physical disability typically does not affect fertility or the desire for a family, it is important to understand the course of pregnancy among affected women. Evidence shows that women with varying definitions of disability are more likely to have babies born with low birth weights or prematurely. The limited research available suggests that relevant risk factors for these birth outcomes tend to be more common in pregnant women with varying disabilities compare to the general population. For example, cigarette smoking, alcohol drinking, and obesity increase risks of adverse outcomes and appear to be disproportionately higher in pregnant women with disabilities. However no study to date has examined pregnancy exposures in relation to adverse birth outcomes among women with physical disabilities. In women of childbearing ages, physical disabilities most often stem from congenital muscular and neuromuscular defects (cMND), defined as spina bifida, cerebral palsy, muscular dystrophy, and limb anomalies (contractures, missing or shortened). Impairments in mobility and dexterity can impact activities of daily living and result in chronic pain, sleep disturbances, and psychosocial problems. Medications needed for the treatment of these symptoms, and other behavioral coping mechanisms, may be associated with birth outcomes, raising further the need to study the course of pregnancy and birth outcomes among cMND-affected women. This study will take advantage of rich data resource - the Boston University Slone Epidemiology Center Birth Defects Study. From 1976 to 2015, over 68,000 mothers of babies born with and without congenital anomalies were asked detailed questions about a range of events and exposures during pregnancy for the purpose of identifying risk factors for birth defects. Women were specifically asked if they were born with spina bifida or any anomalies of the brain, head, spine, spinal cord, muscles, bones, arms, or legs. This study will compare the 132 women who were identified as having a cMND to 528 unaffected women for the following pregnancy exposures: cigarette smoking, alcohol intake, pre- pregnancy body mass index, vitamin supplementation, kidney/bladder infection, pain medications, sleep medications, and psychoactive medications. Comparisons of common adverse birth outcomes will include premature birth, low birth weight, and macrosomia. In addition, mediation analyses will measure the amount of an association between cMND and birth outcomes that is mediated through pregnancy exposures. An estimated 212,000 US women of childbearing ages have a cMND, for whom pregnancy may require special services. It is necessary to understand the course of pregnancy and outcomes among women with congenital physical disabilities as a step toward ensuring optimal care and risk prevention. This project takes advantage of a unique data resource to provide valuable information for this purpose.
在过去,患有大多数先天性畸形的人的平均寿命大大延长了

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Birth outcomes among women with congenital neuromuscular disabilities.
  • DOI:
    10.1016/j.dhjo.2021.101259
  • 发表时间:
    2022-04
  • 期刊:
  • 影响因子:
    4.5
  • 作者:
    Huezo García M;Parker SE;Petersen JM;Rubenstein E;Werler MM
  • 通讯作者:
    Werler MM
Medication use during pregnancy among women with congenital physical disabilities.
  • DOI:
    10.1002/bdr2.2048
  • 发表时间:
    2022-08-15
  • 期刊:
  • 影响因子:
    2.1
  • 作者:
    Garcia, Michelle Huezo;Petersen, Julie M.;Parker, Samantha E.;Rubenstein, Eric;Werler, Martha M.
  • 通讯作者:
    Werler, Martha M.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARTHA M. WERLER其他文献

MARTHA M. WERLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARTHA M. WERLER', 18)}}的其他基金

Massachusetts Center for Birth Defects Research and Prevention: Birth Defects Study To Evaluate Pregnancy exposureS (BD STEPS Core and Stillbirth)
马萨诸塞州出生缺陷研究和预防中心:评估妊娠暴露的出生缺陷研究(BD STEPS 核心和死产)
  • 批准号:
    10764493
  • 财政年份:
    2023
  • 资助金额:
    $ 8.25万
  • 项目类别:
EXPLORING MODIFIABLE FACTORS FOR FOLIC ACID RESISTANT SPINA BIFIDA
探索叶酸耐药性脊柱裂的可改变因素
  • 批准号:
    9022193
  • 财政年份:
    2015
  • 资助金额:
    $ 8.25万
  • 项目类别:
EXPLORING MODIFIABLE FACTORS FOR FOLIC ACID RESISTANT SPINA BIFIDA
探索叶酸耐药性脊柱裂的可改变因素
  • 批准号:
    9290951
  • 财政年份:
    2015
  • 资助金额:
    $ 8.25万
  • 项目类别:
Nested case-control study of maternal herpes viruses in relation to gastroschisis
母体疱疹病毒与腹裂相关的巢式病例对照研究
  • 批准号:
    8511889
  • 财政年份:
    2013
  • 资助金额:
    $ 8.25万
  • 项目类别:
RISK FACTORS FOR FOLIC ACID-RESISTANCE SPINA BIFIDA
叶酸抵抗性脊柱裂的危险因素
  • 批准号:
    8141377
  • 财政年份:
    2010
  • 资助金额:
    $ 8.25万
  • 项目类别:
RISK FACTORS FOR FOLIC ACID-RESISTANCE SPINA BIFIDA
叶酸抵抗性脊柱裂的危险因素
  • 批准号:
    8521091
  • 财政年份:
    2010
  • 资助金额:
    $ 8.25万
  • 项目类别:
RISK FACTORS FOR FOLIC ACID-RESISTANCE SPINA BIFIDA
叶酸抵抗性脊柱裂的危险因素
  • 批准号:
    8307734
  • 财政年份:
    2010
  • 资助金额:
    $ 8.25万
  • 项目类别:
RISK FACTORS FOR FOLIC ACID-RESISTANCE SPINA BIFIDA
叶酸抵抗性脊柱裂的危险因素
  • 批准号:
    8910874
  • 财政年份:
    2010
  • 资助金额:
    $ 8.25万
  • 项目类别:
RISK FACTORS FOR FOLIC ACID-RESISTANCE SPINA BIFIDA
叶酸抵抗性脊柱裂的危险因素
  • 批准号:
    8048731
  • 财政年份:
    2010
  • 资助金额:
    $ 8.25万
  • 项目类别:
Maternal Vasoactive Exposures and Risk of Clubfoot
母体血管活性物质暴露和马蹄内翻足的风险
  • 批准号:
    7582685
  • 财政年份:
    2009
  • 资助金额:
    $ 8.25万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 8.25万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.25万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 8.25万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.25万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 8.25万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.25万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 8.25万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 8.25万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 8.25万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 8.25万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了